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Improved in vivo detection of cortical lesions
in multiple sclerosis using double inversion
recovery MR imaging at 3 Tesla
Abstract Objective: To investigate
the impact of a higher magnetic field
strength of 3 Tesla (T) on the detec-
tion rate of cortical lesions in multiple
sclerosis (MS) patients, in particular
using a dedicated double inversion
recovery (DIR) pulse sequence.
Methods: Thirty-four patients with
clinically isolated syndromes or
definite MS were included. All
patients underwent magnetic reso-
nance imaging (MRI) at 1.5 Tand 3 T,
including T2-weighted turbo spin
echo (TSE), fluid-attenuated inversion
recovery (FLAIR) and DIR
sequences. All images were analysed
for focal lesions categorised accord-
ing to their anatomical location.
Results: The total number of detected
lesions was higher at 3 T across all
pulse sequences. We observed signif-
icantly higher numbers of lesions
involving the cortex at 3 T using a
DIR sequence. DIR at 3 T showed
192% more pure intracortical
(p<0.001) and 30% more mixed grey
matter-white matter lesions
(p=0.008). No significant increase in
cortical lesions could be detected on
the FLAIR and T2-weighted images.
Using the T2-weighted and FLAIR
sequences, significantly more lesions
could be detected at 3 T in the
infratentorial, periventricular and
juxtacortical white matter.
Conclusion: DIR brain MR imaging
at 3 T substantially improves the
sensitivity of the detection of cortical
lesions compared with the standard
magnetic field strength of 1.5 T.
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Introduction
Multiple sclerosis (MS) is the most common chronic
inflammatory disease of the central nervous system (CNS)
in young adults and is characterised by the presence of
multifocal inflammatory demyelinating lesions dissemi-
nated in space and in time [1, 2]. Although MS has been
considered a disease primarily affecting the white matter, it
has been conclusively shown that MS lesions occur
abundantly in the grey matter as well [2, 3].
Magnetic resonance imaging (MRI) is the most sensitive
paraclinical method in the detection of focal and diffuse
abnormalities in the brain of MS patients. Using conven-
tional MRI techniques, MS lesions are frequently and
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Amsterdam, The Netherlandstypically detected in certain anatomical regions, such as the
periventricular,juxtacorticalandinfratentorialwhitematter,
which is reflected by current MRI and clinical diagnostic
criteria [1, 2, 4–7]. However, despite the histopathological
abundance of cortical lesions in MS patients, the sensitivity
of MRI in the detection of cortical lesions remains rather
low [3, 8].
Because of the substantial increase in the signal-to-noise
ratio (SNR), high-field MRI beyond 1.5 Tesla (T) offers
several advantages and new possibilities especially in the
field of neuroimaging [9]. In patients with suspected and/or
definite MS, high-field MRI provides higher lesion load
measurements of acute and chronic white matter lesions.
This higher sensitivity becomes specifically obvious in
anatomical regions that are important for the diagnosis and
prognosis of MS [10]. However, whether higher magnetic
field strengths also provide an improved in vivo detection
of cortical abnormalities has not been investigated and
remains questionable.
The aim of our study was to investigate the impact of a
higher magnetic field strength of 3 T on the detection rate
of cortical lesions in MS patients, in particular using a
dedicated double inversion recovery (DIR) pulse sequence.
Materials and methods
Study design
This study was designed as an intraindividual comparative
study in patients with a clinically isolated syndrome (CIS)
suggestive of MS or patients with definite MS. The study
protocol was approved by the local institutional review
board and written informed consent was obtained from all
participants. Inclusion criteria were: CIS of the central
nervous system (CNS) suggestive of MS or definite MS as
defined by the International Panel on MS diagnosis [2];
exclusion criteria were: any vascular, malignant and other
immunological CNS diseases in the present and/or past
medical history.
Patients and healthy controls
Thirty-four patients (26 female; median age at the time of
MR examination 38 years, range 22–52 years) and nine
healthy controls (three male, six female; median age at the
time of MR examination 34 years, range 24–61.5 years)
were included in this study. Two patients presented with a
CIS and 32 patients had a relapsing-remitting course of MS
(RR-MS) according to the revised International Panel
criteria on MS diagnosis [2]. None of the patients received
any treatment with corticosteroids in the month before the
MR examination. All patients with RR-MS were under
immune-modifying treatment at the time of the MR
examination. The median disease duration (estimated
from the first clinical event) of the CIS patients was
6.5 months (patient 1, 3 months; patient 2, 10 months), and
8 years (range 2 months to 26.3 years) for the RR-MS
group. The median disability score of the patients
according to the Expanded Disability Status Scale [11]a t
the time of the MRI examination was 1.6 (range 0–4),
indicating mild disability.
MRI
The MR examination was performed on 1.5-T and 3-T
whole-body MRI (Achieva, Philips Medical Systems, Best,
the Netherlands). The examinations at both field strengths
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Table 1 Sequence parameters used at 1.5 T and 3T (TR repetition time, TE echo time, IR inversion recovery, SENSE sensitivity encoding,
NSA numbers of signals averaged)
System 1.5 T 3 T 1.5 T 3 T 1.5 T 3 T
Parameter FLAIR T2 TSE DIR
Orientation Transverse Transverse Transverse Transverse Transverse Transverse
Number of sections 40 40 40 40 40 40
Slice thickness/gap (mm) 3/0 3/0 3/0 3/0 3/0 3/0
Measured voxel size (mm) 1/1/3 1/1/3 1/1/3 1/1/3 1/1/3 1/1/3
Echo train 21 38 18 40 16 13
TR (ms) 6,000 12,000 4,100 5,100 13,092 11,000
TE (ms) 140 140 100 100 25 25
IR delay (ms) 2,000 2,850 ––3,400/325
a 3,400/325
a
SENSE factor 1.9 1.35 1 1 – 2
N S A 212122
Imaging time (min:s) 5:12 4:00 3:41 1:42 8:17 6:36
aThe long inversion time TI1 (3,400 ms) is defined as the interval between the first 180° inversion pulse and the 90° excitation pulse. The
short inversion time TI2 (325 ms) is defined as the interval between the second 180° inversion pulse and the 90° excitation pulsewere performed in a randomised order within a time
interval of 12 h. Both MRIs were equipped with standard
gradients (a maximum slew rate of 150 mT/m/ms and a
maximum strength of 30 mT/m). For the examinations at
both MRI systems, an eight-element phased array sensi-
tivity encoding (SENSE) head-coil (Philips Medical
Systems, Best, the Netherlands) was used.
The imaging protocol at both field strengths included 40
contiguous sections in two-dimensional (2D) transverse
orientation of the following pulse sequences: T2-weighted
turbo spin echo (TSE), fluid-attenuated inversion recovery
(FLAIR) and DIR. The MR sequence parameters were
separately optimised for 1.5 T and 3 T. The parameters are
given in detail in Table 1. The same repositioning was used
for all pulse sequences across both 1.5-T and 3-T MRIs
according to the Consortium of MS Centers consensus
guidelines [12].
Image analysis
The image analysis was performed by two radiologists in
consensus, each with experience of at least 5 years in
neuroradiology and with special expertise in the field of
inflammatory demyelinating diseases such as MS. The
images were analysed at a digital workstation (Centricity
Radiology RA 600 version 6.1, General Electrics Medical
Systems, USA) and the order of analysis randomised for
the different pulse sequences of the MR examinations.
Both readers were blinded to the clinical presentation and
paraclinical tests (visual evoked potentials, CSF analysis,
blood tests). The images of healthy controls were evaluated
in terms of artefacts that mightimpair the diagnostic quality
and lead to false-positive or -negative results. All images
obtained from the patient group were analysed for focal
lesions, which were categorised according to their ana-
tomical location in: pure cortical, mixed white matter-grey
matter, deep grey matter, juxtacortical, deep white matter,
periventricular white matter and infratentorial lesions.
Regarding the white matter lesions, we considered focal
high signal intensity lesions with a size of ≥3 mm. The
classification in terms of different anatomical locations was
performed according to published criteria [4, 5]. Intracor-
tical lesions and mixed white matter-grey matter lesions
were defined as focal lesions with higher signal intensity
than the normal appearing grey matter. Intracortical lesions
were further defined as lesions purely located in the cortex
not involving the white matter. Abnormalities only
involving the subpial layer of the cortex suggesting subpial
demyelination were not considered. White matter-grey
matter lesions were defined as lesions partially located in
the white matter as well as in the cortical grey matter. The
criteria for the identification and classification of cortical
lesions were adapted from recently published studies [3, 8,
13, 14]. In order to avoid false positive results due to
artefacts (in particular on the DIR), we discriminated
between lesions and artefacts by considering images
obtained from healthy control subjects.
Statistical methods
The relative comparison of numbers of lesions seen on 3 T
versus 1.5 T for each type of sequence and separated for
different anatomical locations was expressed as a percen-
tage of the lesion number seen on 1.5-T MRI. A positive
relative comparison indicates an increase in lesions
identified at 3 T (higher sensitivity), whereas a negative
relative comparison indicates a decrease in the number of
detected lesions at 3 T (lower sensitivity).
The statistical evaluation of the patient-based analysis
in terms of lesion load measurements (number of lesions)
on 3 T and 1.5 T, respectively, was performed with the
Wilcoxon test for matched pairs. In order to account for
clustering (repeated measurement) a negative binomial
regression model with robust sandwich estimators was
performed. In the case of a significant interaction
between method (different pulse sequences: T2-weighted
TSE, FLAIR, DIR) and technique (different magnetic
field strengths: 1.5 T, 3 T) the differences between the
techniques were tested and adjusted for multiple com-
parisons (Bonferroni p values).
P values <0.05 were considered statistically significant.
The data were analysed using SPSS version 17.0 (SPSS,
Chicago, Ill., USA) and Stata version 10.0 (Stata, College
Station, Tex., USA) for the negative binominal model.
Results
Healthy control subjects
Focal lesions, artefacts
The MR examinations of the eight healthy controls at both
field strengths showed 13, 17 and nine lesions on the T2-
weighted TSE, FLAIR and DIR respectively. Most of the
lesions were located in the deep white matter [11 (85%) on
T2-weighted TSE, ten (59%) on FLAIR, six (67%) on
DIR]. The remaining lesions were located in the periven-
tricular white matter. Cortical lesions could not be
identified on any of the used pulse sequences in any
control subject.
DIR sequences of the healthy control subjects at 1.5 T
and 3 Tshowed comparably high signal changes of certain
cortical areas particularly involving the archicortex and
palaeocortex as previously described [13, 15]. Moreover,
artefacts duetovessel andCSFpulsationcouldbe observed
more frequently and prominently on DIR sequences at both
field strengths compared with FLAIR and T2-weighted
TSE. These artefacts were particularly located in the
posterior fossa close to the fourth ventricle, around the
1677mesencephalic aqueduct and close to the choroid plexus
(Fig. 1).
MS and CIS patients
All included patients (CIS and MS) showed focal lesions
on MRI. The numbers of detected lesions at both field
strengths separated according to their anatomical locations
are listed in Table 2. The data of a patient-based analysis
are presented in Table 3. The total number of lesions
detected was higher at 3 T compared with 1.5 T across all
pulse sequences. Separated by different anatomical loca-
tions, the lesion load at 3 T was significantly higher in the
periventricular (p=0.016) and deep white matter regions
(p=0.002) for the T2 weighted TSE, and in the infra-
tentorial (p=0.012), periventricular (p=0.027), juxtacor-
tical (p=0.005) and deep white matter regions (p<0.001)
for the FLAIR sequence. For the DIR sequence, the
higher lesion count at 3 T reached statistical significance
for the infratentorial (p<0.001), juxtacortical (p=0.001)
and deep white matter region (p<0.001), but also
regarding the pure intracortical (p<0.001) and mixed
grey matter-white matter lesions (p=0.008) (Figs. 1, 2, 3
and 4).
The negative binomial regression model showed no
significant interaction between the magnetic field strength
and pulse sequences regarding the total number of lesions
(p=0.067). Considering the subgroup analysis for different
anatomical locations, a positive interaction between the
magnetic field strength and pulse sequence was significant
for intracortical (p=0.004) and infratentorial lesions (p<
0.0001). Separated by the different pulse sequences, it
became obvious that this interaction was driven by a
significantly increased detection rate for FLAIR (p=
0.0026; adjusted for multiple comparisons, p=0.0078)
and DIR (p<0.0001; adjusted for multiple comparisons,
p<0.0001) but not for T2 TSE (p=1) regarding infra-
tentorial lesions. Concerning intracortical lesions this
effect was only significant for the DIR (p<0.0001;
adjusted for multiple comparisons, p<0.0001) but not for
the FLAIR (p=0.40; adjusted for multiple comparisons,
p=1) andT2 TSE sequences (p=0.49; adjusted for multiple
comparisons, p=1).
Discussion
Since gaining the approval of the American Food and Drug
Administration (FDA) in 2002, the advantages and
challenges of brain imaging using clinical high-field MRI
at 3 T have been extensively investigated. In patients with
CIS suggestive of MS and definite MS, it has been
conclusively shown that imaging at higher magnetic field
strengths leads to significantly higher lesion load measure-
ments [16–18]. This is particularly obvious in anatomical
regions that are highly important for the diagnosis of MS in
the context of diagnostic criteria and prognostic purposes
such as the juxtacortical, periventricular and infratentorial
white matter [10, 16–18]. Contrary to these studies, which
were performed with a rather low spatial resolution using a
slice thickness of 5 mm, we used a higher spatial resolution
Fig. 1 Transverse sections of the infratentorial brain at 3 T (top row)
and 1.5 T (bottom row) obtained from a 50-year-old woman with
relapsing-remitting MS. The DIR sequence (left column)i sa b l et o
detect more infratentorial lesions at 3 Tcompared with 1.5 Tand other
pulse sequences such as FLAIR (middle column) and T2 TSE (right
column). Those lesions can also affect the cortex (closed arrowhead).
Please note the higher propensity of DIR to vessel and CSF pulsation
artefacts particularly in the posterior fossa (open arrowhead)
1678with a slice thickness according to current imaging
guidelines and obtained concordant results. Using 3-T
MRI, we were able to identify significantly more lesions
than at 1.5 T in the periventricular white matter on the T2
TSE and additionally in the juxtacortical and infratentorial
white matter on the FLAIR sequence. The DIR provided
the highest lesion load measurement within the posterior
fossa at both field strengths. Beside diagnostic imaging
criteria, this finding is of special prognostic interest, as it
has been shown that the number of infratentorial lesions at
baseline plays an important prognostic role in the
prediction of long-term disability in patients presenting
with CIS suggestive of MS [19].
MS has been traditionally considered as a chronic
inflammatory disease predominantly affecting the white
matter of the CNS, which is somehow reflected by the high
sensitivity of MRI in the detection of focal and diffuse
white matter abnormalities in MS patients. However,
pathological studies have convincingly shown that cortical
grey matter lesions occur abundantly in MS across all
different disease courses and are linked to certain clinical
manifestations such as physical disability, cognitive
impairment and epilepsy [3, 20, 21]. From the radiological
point of view, grey matter manifestations in MS have been
disregarded for a long time because of the low sensitivity of
conventional MRI techniques in the detection of cortical
lesions. As it has been shown that DIR sequences,
simultaneously suppressing CSF and the white matter,
are able to increase the detectability of grey matter lesions
in MS significantly [13], the possible role of MRI in
detecting grey matter changes in MS has become a major
focus of interest. Currently, DIR applications at 1.5 T are
increasingly being used to detect and quantify cortical
lesion load in MS patients as well as to correlate these
measures with the clinical course, outcome measures and
symptom manifestations [14, 22–23]. Compared with
Table 3 Patient-based analysis. Data represent the number of patients with more lesions detected at 1.5 T or 3 T respectively categorised
according to different anatomical regions
T2 FLAIR DIR
Region More lesions at
1.5 T
More lesions
at 3 T
p
value
a
More lesions at
1.5 T
More lesions
at 3 T
p
value
a
More lesions at
1.5 T
More lesions
at 3 T
p
value
a
Intracortical 4 1 0.750 3 5 0.563 0 26 <0.001
Mixed GM-
WM
6 8 0.540 6 14 0.483 2 14 0.008
Deep GM 2 3 1.000 3 3 1.000 2 2 1.000
Juxtacortical 10 16 0.136 6 21 0.005 5 20 0.001
Deep WM 6 21 0.002 5 23 <0.001 3 24 <0.001
Periventricular 9 17 0.016 8 18 0.027 9 17 0.060
Infratentorial 9 7 0.993 3 11 0.012 1 20 <0.001
Total 9 20 0.002 5 27 <0.001 3 30 <0.001
aP value obtained by Wilcoxon’s test for matched pairs. P values < 0.05 are considered statistically significant
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Table 2 Numbers of lesions detected at 1.5 T and 3 T categorised according to different anatomical regions (GM grey matter, WM white
matter)
T2 FLAIR DIR
Region 1.5 T 3 T Relative comparison
a 1.5 T 3 T Relative comparison
a 1.5 T 3 T Relative comparison
a
Intracortical 7 5 − 29 10 13 +30 26 76 +192
Mixed GM-WM 44 50 +14 70 84 +20 76 99 +30
Deep GM 3 4 +33 3 4 +33 5 5 0
Juxtacortical 350 389 +11 381 449 +18 286 354 +24
Deep WM 448 513 +15 516 609 +18 408 518 +27
Periventricular 342 392 +15 424 468 +10 434 464 +7
Infratentorial 64 64 0 46 75 +63 77 121 +57
Total 1,258 1,417 +13 1,450 1,702 +19 1,312 1,637 +25
aData represent relative differences in the numbers of lesions detected at 3 T vs 1.5 T expressed as percentagesstandard pulse sequences such as FLAIR and T2 TSE,
substantial drawbacks of DIR applications at 1.5 T are the
higher propensity to produce artefacts (in particular
because of vessel and CSF flow) but also the relatively
low SNR due to the application of two consecutive
inversion pulses. These factors can substantially impair
the image quality and diagnostic accuracy in many disease
entities [24–26]. Because of the higher SNR, imaging at
higher magnetic field strengths is, therefore, a promising
application of DIR imaging, allowing a further character-
isation of cortical structures even with a high spatial
resolution [27].
In agreement with recent studies at 1.5 T and 3 T, our
study showed that DIR is of greater benefit in the detection
of pure intracortical and mixed white matter-grey matter
lesions compared with FLAIR or conventional T2-
weighted TSE sequences at both field strengths. This
finding is mainly based on two different observations: on a
better contrast between lesions and the surrounding
normal-appearing grey matter due to a slight attenuation
of the cortex itself on DIR [13], and also because of a better
distinction between pure cortical, mixed white matter-grey
matter and juxtacortical lesions on DIR images [13, 28].
Many of these lesions are scored as juxtacortical on
conventional T2-weighted FLAIR images leading to a high
amount of juxtacortical lesions and rather low numbers of
cortical lesions [29]. This explains the relatively lower
numbers of juxtacortical lesions on DIR images (regardless
of the field strength used) because many of these lesions
were classified as pure cortical or mixed white matter-grey
matter lesions.
Fig. 2 Transverse sections of
the supratentorial brain of a
31-year-old man with relapsing-
remitting MS. Upper row
images were obtained at 3 T,
bottom row images were
obtained at 1.5 T. Left column
DIR images, middle column
FLAIR images, right column T2
TSE images. The 3-T images
offer better image quality
allowing better delineation of
focal inflammatory lesions,
regardless of the specific
anatomical location. At both
field strengths, the DIR
sequence allows a better classi-
fication of lesions close to the
cortex or in the cortex itself as
juxtacortical lesions (closed-
head arrows) or cortical lesions
and mixed white matter-grey
matter lesions (open-head
arrows), respectively. In
particular, the DIR at 3 T shows
more lesions purely located in
the grey matter and lesions
partially located in the grey and
white matter
Fig. 3 Transversal sections of a DIR sequence at 1.5 T (left) and 3 T
(right) from a 44-year-old woman with relapsing-remitting MS.
Please note the higher conspicuity and improved detection of a
lesion purely located in the cortex (closed-head arrow). Please note
also the diffuse high signal changes in the parasagittal cingulate
cortex which can also be frequently observed in healthy control
subjects and have to be considered artefacts (open-head arrow)
1680Moving to higher magnetic field strengths, the results of
our studies have shown that 3-T MRI allows a significantly
higher in vivo lesion load measurement of cortical lesions in
MS patients compared with 1.5 T. However, this higher
sensitivity in the detection of cortical lesions using 3 Tinstead
of 1.5 Twas only present on DIR and was not significant for
the T2-weighted or FLAIR sequences. DIR was the only
sequence for which 3 Tshowed a significant increase in both
pure cortical and mixed white matter-grey matter lesions.
Keeping in mind that cortical lesions correlate strongly with
clinical outcome measures such as cognitive impairment and
physical disability [14, 20], the clinical relevance of higher in
vivo cortical lesion load measurement using clinical high-
field MRI operating at 3 T becomes even more obvious.
The higher cortical lesion load at 3-T MRI using DIR is
probably based on a higher SNR and on the re-classifica-
tion of juxtacortical lesions into pure cortical or mixed
white matter-grey matter lesions. This can, of course, have
substantial consequences in terms of classification of
patients (particularly CIS patients) according to MRI
criteria [5–7]. As 3-T MRI systems are increasingly
being used in a clinical routine setting and multi-centre
treatment trials, this higher lesion load of cortical lesions at
3 Tand the substantial clinical relevance of cortical lesions
are good arguments when considering cortical lesions for
future imaging and diagnostic criteria.
However, compared with histopathological studies
showing up to nearly 60% of the lesion load in MS
patients to be located in cortical areas, we have to be aware
that the sensitivity of MRI using DIR even at 3 T remains
relatively rather low. Only 10% of all detected lesions on
DIR at 3 T were (at least partially) located in the cortex.
The next step might be to investigate whether the next
generation of whole-body high-field MRI operating at 7 T
can further increase the in vivo detection of cortical lesions.
First results are promising but also challenging in particular
with regard to the implementation of DIR imaging
techniques [30–33].
A limitation of our study is that our image analysis of
cortical lesions was limited to the classification of pure
cortical and combined (mixed) grey matter-white matter
lesions. Although we applied a spatial resolution according
to current MS imaging guidelines, we did not try to further
classify cortical lesions according to histopathological
cortical lesion-type classification. In particular, subpial
demyelination, which is the most frequent type of lesion
manifestation in the cortex, cannot be reliably visualised on
MRI even using ultra-high-field MRI because of a lack of
myelin in the superficial cortical layers and a lack of
inflammation [34, 35]. Moreover, our study is based on
two-dimensional (2D) pulse sequences. The implementa-
tion of 3D sequences allowing the acquisition of high-
resolution imaging with isotropic voxels and reducing flow
artefacts might further increase the lesion count of cortical
lesions [13, 36–37]. Additionally, we have to be aware that
the readers might not have been sufficiently blinded to the
images in terms of the magnetic field strength. Although
the readers were formally blinded to the magnetic field
strengths, they might have been able identify the 3-T and
1.5-T image by analysing the better image quality and
lesion conspicuity on 3 T. This could have resulted in a
certain reading bias, which cannot be avoided, however,
and is a limitation for all intra-individual magnetic field
strength comparisons.
In conclusion, the combination of 3-T MRI and a
dedicated DIR pulse sequencel e a d st oas i g n i f i c a n t l y
higher sensitivity for the detection of cortical lesions in
MS patients, which might lead to considerable con-
sequences for future imaging studies dealing with
clinical outcome measures and diagnostic criteria.
Fig. 4 Two consecutive DIR sections of the supratentorial brain of a
31-year-old man with relapsing-remitting MS obtained at 1.5 T (top
row) and 3 T (bottom row). The DIR sequence benefits from the
higher signal at 3 T leading to better delineation of the cortex and
inflammatory lesions affecting the cortex (close-headed arrows).
Please note also diffuse symmetric high signal changes in the
occipital cortex (open-head arrows) which do not represent real
cortical abnormalities and have to be considered artefacts
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